| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Bo Jiang CEO | SSE Exchange | CNE0000009T3 ISIN |
| CN Country | 9,853 Employees | 4 May 2018 Last Dividend | 6 Apr 2016 Last Split | 1 Feb 1990 IPO Date |
Harbin Pharmaceutical Group Co., Ltd., based in Harbin, China, is a prominent entity in the pharmaceutical industry, recognized for its extensive involvement in the research, development, manufacture, and trading of pharmaceuticals both domestically and internationally. With a focus on innovation and quality, the company has established a strong presence in the healthcare sector by providing a wide range of pharmaceutical products designed to meet the diverse needs of patients worldwide.
The company's product portfolio is extensive and diversified, covering various therapeutic areas. These include:
These products are made available under several reputable brands including Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang, reflecting the company's commitment to quality and patient care.